Protection from hypoxic and N-methyl-D-aspartate injury with azelastine, a leukotriene inhibitor
- 20 July 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (2-3) , 165-171
- https://doi.org/10.1016/0014-2999(93)90844-8
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Leukotriene C4 and prostaglandin E2 activities in the serum and cerebrospinal fluid during acute cerebral ischemiaProstaglandins, Leukotrienes & Essential Fatty Acids, 1991
- AzelastineDrugs, 1989
- The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor-binding sitesJournal of Allergy and Clinical Immunology, 1989
- Inhibition of Allergic and Nonallergic Leukotriene C4 Formation and Histamine Secretion by Azelastine: Implication for Its Mechanism of ActionInternational Archives of Allergy and Immunology, 1989
- NMDA receptors activate the arachidonic acid cascade system in striatal neuronsNature, 1988
- Inhibition of cysteinyl-leukotriene production by azelastine and its biological significanceInflammation Research, 1988
- A hypoxic injury potential in the hippocampal sliceBrain Research, 1988
- Mechanisms of arachidonic acid-induced contractions of canine cerebral arteriesEuropean Journal of Pharmacology, 1987
- Formation of leukotriene C4-like material by rat brain tissueEuropean Journal of Pharmacology, 1984
- HETEROGENEITY OF HISTAMINE Hi‐RECEPTORS: SPECIES VARIATIONS IN [3H]MEPYRAMINE BINDING OF BRAIN MEMBRANESJournal of Neurochemistry, 1979